Nasopharyngeal Carcinoma CTCs Specified Screening
mRNA Circulating Tumor Cells Specified Screening can analyse 30-32 mRNA molecular marker detailedly and access the efficacy of ongoing treatment, postoperative and prognostic tracking in order to investigate a more suitable treatment for the patient. Specially suitable for patient who need to track the Circulating Timor Cells specifically, cancerous person, postoperative cancer tracking and prognostic tracking.
Listed Price is $4,800 and now is $3,000 for the promotional period! Please contact 3168-8188, WhatsApp 6218-8534 or Facebook inbox for more information.
Click Here：To know more about mRNA Circulating Tumor Cells Screening
| Nasopharyngeal Carcinoma CTCs Specified ScreeningmRNA-NPCA | ||
| Characteristics: | ||
| Analyzing 30-32 mRNA molecular marker detailedly | ||
| Analyzing the specificity of Tumor | ||
| Accessing the efficacy of ongoing treatment, postoperative and prognostic tracking | ||
| Investigating a more suitable treatment for the patient | ||
| Suitable for: | ||
| Need to track the Circulating Timor Cells specifically | ||
| Cancerous person | ||
| Unhealthy eating, smoking and eating habits | ||
| Postoperative cancer tracking | ||
| Prognostic tracking | ||
| New Advanced technology- mRNA Circulating Tumor Cells Screening | ||
| Technology R & D: Eegene International Biotechnology Company Limited |
| HKD$3,000 |